Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-α and ribavirin

被引：10
|
作者：
Misery, L [1 ]
机构：
[1] Univ Hosp, Dept Dermatol, Brest, France
来源：
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 2002年 / 22卷 / 08期
关键词：
D O I：
10.1089/107999002760274890
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A 32-year-old man suffered from hemophilia and hepatitis C. Treatment by interferon-alpha (IFN-alpha) and ribavirin was prescribed. After 6 months, the patient noted a diffuse hair growth, whereas he was beardless before treatment. This hypertrichosis was treated by laser therapy. No hypertrichosis is known in patients with hemophilia or viral hepatitis. Ribavirin has not been described as an inducer of hair growth. IFN-alpha is known to induce telogen effluvium, but some cases of hypertrichosis of the eyelashes or eyebrows have been reported. In this patient, the hypertrichosis is probably caused by IFN.
引用
收藏
页码：881 / 882
页数：2
相关论文
共 50 条
  • [1] Pegylated IFN-α2a and ribavirin in the treatment of hepatitis C
    Aghemo, Alessio
    Rumi, Maria Grazia
    Colombo, Massimo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (08) : 925 - 935
  • [2] Suicidal ideation with IFN-α and ribavirin in a patient with hepatitis C
    Ademmer, K
    Beutel, M
    Bretzel, R
    Clemens, J
    Reimer, C
    PSYCHOSOMATICS, 2001, 42 (04) : 365 - 367
  • [3] Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children
    Pawlowska, Malgorzata
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (03) : 343 - 348
  • [4] Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-α/Ribavirin
    Amati, L
    Caradonna, L
    Magrone, T
    Mastronardi, ML
    Cuppone, R
    Cozzolongo, R
    Manghisi, OG
    Caccavo, D
    Amoroso, A
    Jirillo, E
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (11) : 981 - 993
  • [5] Combination treatment with IFN-α and ribavirin in patients' with chronic hepatitis C and persistently normal ALT.
    Erhardt, A
    Behlen-Wilm, U
    Heintges, T
    Haeussinger, D
    HEPATOLOGY, 2001, 34 (04) : 588A - 588A
  • [6] Intraocular complications of IFN-α and ribavirin therapy in patients with chronic viral hepatitis C
    Damien Sène
    Valérie Touitou
    Bahram Bodaghi
    David Saadoun
    Gabriel Perlemuter
    Nathalie Cassoux
    Jean-Charles Piette
    Phuc Le Hoang
    Patrice Cacoub
    World Journal of Gastroenterology, 2007, (22) : 3137 - 3140
  • [7] Intraocular complications of IFN-α and ribavirin therapy in patients with chronic viral hepatitis C
    Sene, Damien
    Touitou, Valerie
    Bodaghi, Bahram
    Saadoun, David
    Perlemuter, Gabriel
    Cassoux, Nathalie
    Piette, Jean-Charles
    Le Hoang, Phuc
    Cacoub, Patrice
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (22) : 3137 - 3140
  • [8] Hemolytic anemia during pegylated IFN-α2b plus ribavirin treatment for chronic hepatitis C:: Ribavirin is not always the culprit
    Gentile, I
    Viola, C
    Reynaud, L
    Borrelli, F
    Cerini, R
    Ciampi, R
    Piazza, M
    Borgia, G
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (05): : 283 - 285
  • [9] Factors impacting the IFN-α treatment for chronic hepatitis C
    Lu, ZM
    Gao, J
    Yao, GB
    Wu, XH
    Wu, DC
    HEPATOLOGY, 1998, 28 (04) : 717A - 717A
  • [10] Resolution of diabetes in type 2 diabetic patient treated with IFN-α and ribavirin for hepatitis C
    Tahrani, Abd
    Bowler, Lesley
    Singh, Pradip
    Coates, Philip
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (03) : 291 - 293
12345